{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:05:34Z","timestamp":1788505534850,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.contraception.2009.03.018","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T04:25:38Z","timestamp":1242275138000},"page":"436-444","source":"Crossref","is-referenced-by-count":117,"title":["Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel"],"prefix":"10.1016","volume":"80","author":[{"given":"Hans-Joachim","family":"Ahrendt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Makalov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Parke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Mellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2009.03.018_bib1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/0002-9378(88)90203-7","article-title":"Risks and mechanisms of cardiovascular events in users of oral contraceptives","volume":"158","author":"Meade","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2009.03.018_bib2","first-page":"9","article-title":"The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg","volume":"4","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2009.03.018_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0010-7824(97)00157-1","article-title":"A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles","volume":"56","author":"Bannemerschult","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.018_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(95)00191-C","volume":"52","author":"Endrikat","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.018_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2009.03.018_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(80)90010-4","article-title":"A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception","volume":"21","author":"Koetsawang","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.018_bib7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-0528.1979.tb11276.x","article-title":"Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol","volume":"86","author":"Astedt","year":"1979","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2009.03.018_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.1.6056.269","article-title":"The natural oestrogenic hormone oestradiol as a new component of combined oral contraceptives","volume":"1","author":"Astedt","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2009.03.018_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0010-7824(96)00201-6","article-title":"The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days","volume":"54","author":"Csemiczky","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.018_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5122(94)00856-3","article-title":"Oral contraceptive containing natural estradiol for premenopausal women","volume":"21","author":"Hirvonen","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2009.03.018_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5122(88)90023-0","article-title":"New natural oestradiol\/cyproterone acetate oral contraceptive for pre-menopausal women","volume":"10","author":"Hirvonen","year":"1988","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2009.03.018_bib12","first-page":"248","article-title":"A multicenter trial with a new OC using a natural estradiol and cyproterone acetate for women over 35","volume":"6","author":"Hirvonen","year":"1990","journal-title":"Adv Contracep"},{"key":"10.1016\/j.contraception.2009.03.018_bib13","first-page":"105","article-title":"Alternatives of the replacement of ethinylestradiol by natural 17beta-estradiol in dienogest-containing oral contraceptives","volume":"35","author":"Hoffmann","year":"1999","journal-title":"Drugs of Today"},{"key":"10.1016\/j.contraception.2009.03.018_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.contraception.2009.03.018_bib15","first-page":"183","article-title":"Efficacy and tolerability of a combined oral contraceptive containing 17 beta-estradiol and desogestrel","volume":"1","author":"Kivinen","year":"1996","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2009.03.018_bib16","series-title":"Extragenital effects of contraceptives: 4th Congress of the European Society of Contraception, Barcelona, Spain, June 1996","first-page":"39","article-title":"A new low-dose oral contraceptive containing ethinylestradiol, estradiol and dienogest: first experience of its clinical use","author":"Kovacs","year":"1997"},{"key":"10.1016\/j.contraception.2009.03.018_bib17","series-title":"Re-evaluation of contraceptive steroids","first-page":"25","article-title":"Different alternatives for the substitution of ethinylestradiol in oral contraceptives","author":"Moore","year":"1998"},{"key":"10.1016\/j.contraception.2009.03.018_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/00016348709015732","article-title":"Ovulation inhibition with 17 beta-estradiol cyclo-octyl acetate and desogestrel","volume":"66","author":"Schubert","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2009.03.018_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(79)91525-3","article-title":"Natural oestrogens for oral contraception","volume":"2","author":"Serup","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.03.018_bib20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)56210-4","article-title":"Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol","volume":"60","author":"Wenzl","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2009.03.018_bib21","first-page":"59S","article-title":"Ovulation inhibition with four different regimens of a four-phasic estradiol valerate and dienogest oral contraceptive","volume":"109","author":"Endrikat","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.03.018_bib22","first-page":"15S","article-title":"Efficacy and tolerability of a new oral contraceptive containing estradiol and dienogest","volume":"111","author":"Parke","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.03.018_bib23","first-page":"61S","article-title":"Pharmacokinetics and pharmacodynamics of a new four-phasic estradiol valerate and dienogest oral contraceptive","volume":"109","author":"Lu","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.03.018_bib24","author":"European Medicines Agency Committee for Medicinal Products for Human Use (CHMP)"},{"key":"10.1016\/j.contraception.2009.03.018_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.018_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00024677-200605020-00005","article-title":"A comparison of the cycle control, safety, and efficacy profile of a 21-day regimen of ethinylestradiol 20 mug and drospirenone 3 mg with a 21-day regimen of ethinylestradiol 20mug and desogestrel 150mug","volume":"5","author":"Gruber","year":"2006","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.contraception.2009.03.018_bib27","first-page":"517","article-title":"A 19-norprogestin without 17alfa-ethinyl group II: dienogest from a pharmacodynamic point of view","volume":"31","author":"Oettel","year":"1995","journal-title":"Drugs Today"},{"key":"10.1016\/j.contraception.2009.03.018_bib28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1358\/mf.2002.24.10.802320","article-title":"Clinical findings with the oral contraceptive combination ethinylestradiol\/dienogest in the Czech Republic","volume":"24","author":"Golbs","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.contraception.2009.03.018_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1358\/mf.2002.24.10.802320","article-title":"Clinical findings with the oral contraceptive combination ethinylestradiol\/dienogest in Poland","volume":"24","author":"Golbs","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.contraception.2009.03.018_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/13625189909040810","article-title":"The efficacy and tolerability of Valette: a postmarketing surveillance study","volume":"4","author":"Zimmermann","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T22:10:28Z","timestamp":1558303828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782409001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0010782409001127"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2009.03.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.722795021.793503811","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}